BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15229245)

  • 21. Prion infection of differentiated neurospheres.
    Herva ME; Relaño-Ginés A; Villa A; Torres JM
    J Neurosci Methods; 2010 May; 188(2):270-5. PubMed ID: 20206206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral circulation of the prion infectious agent in transgenic mice expressing the ovine prion protein gene in neurons only.
    Crozet C; Lezmi S; Flamant F; Samarut J; Baron T; Bencsik A
    J Infect Dis; 2007 Apr; 195(7):997-1006. PubMed ID: 17330790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spreading of prions from the immune to the peripheral nervous system: a potential implication of dendritic cells.
    Dorban G; Defaweux V; Heinen E; Antoine N
    Histochem Cell Biol; 2010 May; 133(5):493-504. PubMed ID: 20238136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro.
    Vorberg I; Raines A; Priola SA
    J Biol Chem; 2004 Jul; 279(28):29218-25. PubMed ID: 15133048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scrapie-specific neuronal lesions are independent of neuronal PrP expression.
    Jeffrey M; Goodsir CM; Race RE; Chesebro B
    Ann Neurol; 2004 Jun; 55(6):781-92. PubMed ID: 15174012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allelic Interference in Prion Replication Is Modulated by the Convertibility of the Interfering PrP
    Espinosa JC; Andreoletti O; Marín-Moreno A; Lugan S; Aguilar-Calvo P; Cassard H; Lorenzo P; Douet JY; Villa-Díaz A; Aron N; Prieto I; Huor A; Torres JM
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protease-resistant prion protein produced in vitro lacks detectable infectivity.
    Hill AF; Antoniou M; Collinge J
    J Gen Virol; 1999 Jan; 80 ( Pt 1)():11-14. PubMed ID: 9934677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prion infection of mouse neurospheres.
    Giri RK; Young R; Pitstick R; DeArmond SJ; Prusiner SB; Carlson GA
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3875-80. PubMed ID: 16495413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolving views in prion glycosylation: functional and pathological implications.
    Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
    Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes.
    Le Dur A; Béringue V; Andréoletti O; Reine F; Laï TL; Baron T; Bratberg B; Vilotte JL; Sarradin P; Benestad SL; Laude H
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):16031-6. PubMed ID: 16239348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene.
    Büeler H; Raeber A; Sailer A; Fischer M; Aguzzi A; Weissmann C
    Mol Med; 1994 Nov; 1(1):19-30. PubMed ID: 8790598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein.
    Telling GC; Scott M; Mastrianni J; Gabizon R; Torchia M; Cohen FE; DeArmond SJ; Prusiner SB
    Cell; 1995 Oct; 83(1):79-90. PubMed ID: 7553876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subclinical prion disease induced by oral inoculation.
    Thackray AM; Klein MA; Bujdoso R
    J Virol; 2003 Jul; 77(14):7991-8. PubMed ID: 12829838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies.
    Heppner FL; Musahl C; Arrighi I; Klein MA; Rülicke T; Oesch B; Zinkernagel RM; Kalinke U; Aguzzi A
    Science; 2001 Oct; 294(5540):178-82. PubMed ID: 11546838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of GPI-anchored PrP C in mediating the neurotoxic effect of scrapie prions in neurons.
    Radford HE; Mallucci GR
    Curr Issues Mol Biol; 2010; 12(2):119-27. PubMed ID: 19767655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanisms of neuroinvasion by prions: molecular principles and present state of research].
    Brandner S; Klein MA; Aguzzi A
    Schweiz Med Wochenschr; 2000 Mar; 130(12):435-42. PubMed ID: 10780058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental transmission of two young and one suspended bovine spongiform encephalopathy (BSE) cases to bovinized transgenic mice.
    Yokoyama T; Masujin K; Yamakawa Y; Sata T; Murayama Y; Shu Y; Okada H; Mohri S; Shinagawa M
    Jpn J Infect Dis; 2007 Sep; 60(5):317-20. PubMed ID: 17881878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoproteolytic processing of the mammalian prion glycoprotein family.
    Mays CE; Coomaraswamy J; Watts JC; Yang J; Ko KW; Strome B; Mercer RC; Wohlgemuth SL; Schmitt-Ulms G; Westaway D
    FEBS J; 2014 Feb; 281(3):862-76. PubMed ID: 24286250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.